Carregant...

HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development

Aberrant activation of the HGF/MET signaling axis has been strongly implicated in the malignant transformation and progression of gastroesophageal cancer (GEC). MET receptor overexpression in tumor samples from GEC patients has been consistently correlated with an aggressive metastatic phenotype and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hack, Stephen P., Bruey, Jean-Marie, Koeppen, Hartmut
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102777/
https://ncbi.nlm.nih.gov/pubmed/24930887
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!